peptide6
General Information
DRACP ID DRACP01592
Peptide Name peptide6
Sequence FLSaIVaMLaKLF
Sequence Length 13
UniProt ID Not available
PubChem CID Not available
Origin analogs of antimicrobial peptide temporin-SHa
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | IC50=26.33 ± 5.8 μM | MTT assay | 24 h | Patent |
HeLa | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | IC50>100 μM | MTT assay | 24 h | Patent |
NCI-H460 | Lung large cell carcinoma | Carcinoma | IC50>100 μM | MTT assay | 24 h | Patent |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity NIH 3T3: IC50>100 μM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification a=D-alanine
Chiral Mix
Physicochemical Information
Formula C61H93N11O9S
Absent amino acids ACDEGHNPQRTWY
Common amino acids L
Mass 137076
Pl 9.7
Basic residues 1
Acidic residues 0
Hydrophobic residues 7
Net charge 1
Boman Index 2308
Hydrophobicity 176.15
Aliphatic Index 142.31
Half Life
/
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US10550155B2
Patent Title Anticancer peptides
Other Iinformation Granted Patent; Family: 2s / 2ex; Family Jurisdictions: US; Legal Status: Active; Application No: 201815937281; Filed: Mar 27, 2018; Published: Feb 4, 2020; Earliest Priority: Mar 27, 2018; Granted: Feb 4, 2020
Other Published ID US10550155B2